ADA 2026

SAN FRANCISCO and SUZHOU, China, May 12, 2026 Innovent Biologics announced that it will present multiple clinical and preclinical...

PHILADELPHIA, Pennsylvania, April 2026 Century Therapeutics announced that its investigational program CNTY-813 has been selected for oral presentation at...